Related Experiment Video
Updated: Jun 6, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Infective endocarditis--a tale of two cases and the lessons (re)learned
Aniruddha G Tembe1, Priyanka Kharbanda, Jamshed J Dalal
1PD Hinduja National Hospital, Mumbai.
Diagnosing infective endocarditis from rare bacteria or unusual locations is difficult. This report highlights challenges in identifying endocarditis caused by HACEK organisms and Pseudomonas aeruginosa.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Diagnostics
Background:
- Infective endocarditis (IE) diagnosis can be challenging, especially with uncommon pathogens or atypical presentations.
- A high index of suspicion is crucial due to nonspecific and variable signs and symptoms.
Observation:
- Two challenging IE cases are presented: one involving a HACEK organism (Eikenella corrodens) in a patient with pre-existing valvular heart disease.
- The second case involved right-sided endocarditis caused by Pseudomonas aeruginosa.
Findings:
- Both cases presented diagnostic difficulties, underscoring the complexity of identifying IE in non-typical scenarios.
- The specific clinical presentations and microbiological findings posed unique diagnostic hurdles.
Implications:
- These cases emphasize the need for heightened clinical awareness and advanced diagnostic strategies for uncommon IE presentations.
- Improved diagnostic approaches are essential for timely and effective management of challenging infective endocarditis cases.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
